Walleye Capital’s Frazier Lifesciences Acquisition Corporation Warrant FLACW Stock Holding History

Walleye Capital’s Portfolio FLACW Stock Details FLACW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-23,487	Closed	-$18K	–	4016
2022 Q3	$18K	Buy	23,487 +4,928	+27%	+$3.13K	﹤0.01%	2743
2022 Q2	$1K	Hold	18,559	–	–	﹤0.01%	2301
2022 Q1	$3K	Sell	18,559 -167	-0.9%	-$73	﹤0.01%	2242
2021 Q4	$11K	Buy	+18,726	New	+$13.1K	﹤0.01%	2023

Walleye Capital's FLACW Position: Q4 2022 in Review

Walleye Capital sold out of Frazier Lifesciences Acquisition Corporation Warrant (FLACW) in Q4 2022, closing a stake of 23,487 shares — an estimated $18K sold.

Walleye Capital first reported a position in FLACW in Q4 2021 and held it in 4 quarters. The position peaked at $18K in Q3 2022. 0 funds tracked by Wall St. Rank hold FLACW as of Q4 2022.

Walleye Capital reported no remaining Frazier Lifesciences Acquisition Corporation Warrant position as of Q4 2022 after selling out during the quarter.
Walleye Capital sold 23,487 Frazier Lifesciences Acquisition Corporation Warrant shares in Q4 2022, an estimated $18K.
Walleye Capital first reported a position in Frazier Lifesciences Acquisition Corporation Warrant in Q4 2021 and held it in 4 quarters.
Walleye Capital's Frazier Lifesciences Acquisition Corporation Warrant position peaked at $18K in Q3 2022.
0 funds tracked by Wall St. Rank held Frazier Lifesciences Acquisition Corporation Warrant as of Q4 2022.

Based on Walleye Capital's 13F filing for Q4 2022, filed 14 Feb 2023.